Literature DB >> 24292284

Effects of multidisciplinary pain treatment can be predicted without elaborate questionnaires.

Christian Alexander Fischer1, Eva Neubauer, Hanne S Adams, Marcus Schiltenwolf, Haili Wang.   

Abstract

PURPOSE: Low back pain is one of the most common and expensive diseases of Western societies. Psychosocial factors such as low social status, depression, or work dissatisfaction are known to promote chronicity of low back pain. With a multidisciplinary approach, better outcomes can be achieved than with purely biomedical treatment. Optimal patient selection for multidisciplinary therapy reduces costs and labour. This study investigated whether elaborated questionnaires exceed simple items in predicting multimodal therapy success.
METHODS: In this prospective longitudinal clinical study, 330 patients were followed up for six months after multidisciplinary therapy. We applied the patient questionnaire Heidelberg Short Early Risk Assessment Questionnaire for the Prediction of Chronicity in Low Back Pain (HKF-R10) that is approved and established for predicting chronicity in patients with acute low back pain to forecast the therapeutic outcome. Outcome criteria were QOL, pain reduction and back to work.
RESULTS: With regard to outcome criteria, the HKF-R10 was unable to anticipate therapeutic success, but education level, depression, best pain condition, and helplessness predicted therapy success with an 80% probability for QOL improvement.
CONCLUSIONS: It is not necessary to confront patients with an extensive and complicated questionnaire to predict the outcome of multidisciplinary therapy. In fact, assessing a few specific items allows better and easier prognosis estimation.

Entities:  

Mesh:

Year:  2013        PMID: 24292284      PMCID: PMC3936078          DOI: 10.1007/s00264-013-2156-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  26 in total

1.  Five questions predicted long-term, severe, back-related functional limitations: evidence from three large prospective studies.

Authors:  Clermont E Dionne; Natalie Le Sage; Renée-Louise Franche; Michel Dorval; Claire Bombardier; Richard A Deyo
Journal:  J Clin Epidemiol       Date:  2010-05-10       Impact factor: 6.437

2.  Ability of early response to predict discharge outcomes with physical therapy for chronic low back pain.

Authors:  Henry C Tong; Michael E Geisser; Aartee P Ignaczak
Journal:  Pain Pract       Date:  2006-09       Impact factor: 3.183

3.  The influence of the grade of chronicity on the outcome of multidisciplinary therapy for chronic low back pain.

Authors:  Matthias Buchner; Eva Neubauer; Anita Zahlten-Hinguranage; Marcus Schiltenwolf
Journal:  Spine (Phila Pa 1976)       Date:  2007-12-15       Impact factor: 3.468

4.  HKF-R 10 - screening for predicting chronicity in acute low back pain (LBP): a prospective clinical trial.

Authors:  Eva Neubauer; Astrid Junge; Peter Pirron; Hanne Seemann; Marcus Schiltenwolf
Journal:  Eur J Pain       Date:  2005-10-03       Impact factor: 3.931

5.  Can we screen for problematic back pain? A screening questionnaire for predicting outcome in acute and subacute back pain.

Authors:  S J Linton; K Halldén
Journal:  Clin J Pain       Date:  1998-09       Impact factor: 3.442

6.  Comparison of a biopsychosocial therapy (BT) with a conventional biomedical therapy (MT) of subacute low back pain in the first episode of sick leave: a randomized controlled trial.

Authors:  Marcus Schiltenwolf; Matthias Buchner; Bernhard Heindl; Johannes von Reumont; Annette Müller; Wolfgang Eich
Journal:  Eur Spine J       Date:  2005-11-26       Impact factor: 3.134

7.  Risk factors of chronicity in lumbar disc patients. A prospective investigation of biologic, psychologic, and social predictors of therapy outcome.

Authors:  M Hasenbring; G Marienfeld; D Kuhlendahl; D Soyka
Journal:  Spine (Phila Pa 1976)       Date:  1994-12-15       Impact factor: 3.468

8.  The Modified Somatic Perception Questionnaire (MSPQ).

Authors:  C J Main
Journal:  J Psychosom Res       Date:  1983       Impact factor: 3.006

9.  Back pain in the German adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey.

Authors:  Carsten Oliver Schmidt; Heiner Raspe; Michael Pfingsten; Monika Hasenbring; Heinz Dieter Basler; Wolfgang Eich; Thomas Kohlmann
Journal:  Spine (Phila Pa 1976)       Date:  2007-08-15       Impact factor: 3.468

10.  [Outcome quality of treatment for chronic low back pain under primary care conditions].

Authors:  E Lang; R Eisele; H Jankowsky; S Kastner; K Liebig; P Martus; B Neundörfer
Journal:  Schmerz       Date:  2000-06       Impact factor: 1.107

View more
  5 in total

1.  Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.

Authors:  Kenneth Pettine; Richard Suzuki; Theodore Sand; Matthew Murphy
Journal:  Int Orthop       Date:  2015-07-10       Impact factor: 3.075

2.  Prevalence, consequences and predictors of low back pain among nurses in a tertiary care setting.

Authors:  Sameh M Abolfotouh; Karim Mahmoud; Khaled Faraj; Gemeh Moammer; Abir ElSayed; Mostafa A Abolfotouh
Journal:  Int Orthop       Date:  2015-07-19       Impact factor: 3.075

Review 3.  [Multimodal therapy programs for chronic pain].

Authors:  A Kopf; E Gjoni
Journal:  Anaesthesist       Date:  2015-02       Impact factor: 1.041

4.  Influence of somatization and depressive symptoms on the course of pain within the first year after uncomplicated total knee replacement: a prospective study.

Authors:  Sebastian Bierke; Martin Häner; Wolf Petersen
Journal:  Int Orthop       Date:  2016-01-28       Impact factor: 3.075

Review 5.  Can screening instruments accurately determine poor outcome risk in adults with recent onset low back pain? A systematic review and meta-analysis.

Authors:  Emma L Karran; James H McAuley; Adrian C Traeger; Susan L Hillier; Luzia Grabherr; Leslie N Russek; G Lorimer Moseley
Journal:  BMC Med       Date:  2017-01-19       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.